683 Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

683 Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-239,800	Closed	-$19.2K	–	305
2023 Q1	$19.2K	Hold	239,800	–	–	﹤0.01%	256
2022 Q4	$36.4K	Hold	239,800	–	–	﹤0.01%	243
2022 Q3	$31K	Hold	239,800	–	–	﹤0.01%	183
2022 Q2	$36K	Hold	239,800	–	–	﹤0.01%	215
2022 Q1	$89K	Hold	239,800	–	–	﹤0.01%	293
2021 Q4	$230K	Hold	239,800	–	–	0.01%	279
2021 Q3	$209K	Buy	+239,800	New	+$312K	0.01%	176

683 Capital Management's ORIAW Position: Q2 2023 in Review

683 Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 239,800 shares — an estimated $19.2K sold.

683 Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $230K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

683 Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
683 Capital Management sold 239,800 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $19.2K.
683 Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
683 Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $230K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.